Jade Simon
Family · Memphis, TNNPI 1023470465
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,111 of the $2,401 with a category attached, or 87.9%. It is spread thinly across 37 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,334, more than ten times the $35 reported in 2021.
Across 95 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$259
- Exelixis Inc.$186
- AstraZeneca$164
- Gilead$145
- Takeda Pharmaceuticals U.S.A., Inc.$144
- Merck$114
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,11188%
- Education$29012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 9 | $259 |
| Exelixis Inc. | 4 | $186 |
| AstraZeneca | 8 | $164 |
| Gilead | 3 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $144 |
| Merck | 5 | $114 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sanofi | 3 | $90 |
| Pfizer | 5 | $88 |
| Incyte Corporation | 4 | $81 |
| Boehringer Ingelheim | 4 | $75 |
| Bayer | 3 | $68 |
| Novartis | 3 | $68 |
| Springworks Therapeutics, Inc. | 2 | $66 |
| Array Biopharma Inc | 4 | $66 |
| GSK | 3 | $61 |
| Legend Biotech USA Inc. | 2 | $51 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Beone Medicines USA, Inc. | 2 | $49 |
| AbbVie | 2 | $41 |
| Karyopharm Therapeutics Inc. | 2 | $36 |
| Taiho Oncology, Inc. | 2 | $34 |
| Eisai Inc. | 2 | $34 |
| Adaptive Biotechnologies Corporation | 1 | $32 |
| Boston Scientific | 1 | $31 |
| Servier Pharmaceuticals LLC | 1 | $28 |
| Geron Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| Caris MPI, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $22 |
| Sobi, Inc | 1 | $21 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Pharmaessentia USA Corporation | 1 | $16 |
How this compares
$2,401 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.
Other family in Memphis
- Marye BernardMemphis$115K
- Brett SnodgrassMemphis$47K
- John ScallionsMemphis$30K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.